FactSet Research Systems Inc.· FDS

Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus

Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.

FactSet Research (FDS) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Baron Focused Growth Fund Q2 2026 Portfolio Update

Baron Focused Growth Fund rebounded in Q2 from a disappointing start to the year, with the Fund gaining 13.26% compared with a gain of 24.02% for the Russell 2500 Growth Index. We remain steadfast in our commitment to long-term investing in competitively advantaged, growth businesses. As of June 30, 2026, the Fund owned 28 investments.

Benjamin Edwards Inc. Grows Stock Position in FactSet Research Systems Inc. $FDS

Benjamin Edwards Inc. increased its stake in shares of FactSet Research Systems Inc. (NYSE: FDS) by 142.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,324 shares of the business services provider's stock after purchasing an additional 1,955

Here's Why FactSet Research (FDS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

FactSet price target lowered to $340 from $380 at UBS

FactSet Research Systems (FDS) PT Lowered to $240 at RBC Capital

FactSet price target lowered to $305 from $311 at BMO Capital

FactSet Research Systems (FDS) PT Lowered to $305 at Jefferies

Morgan Stanley Upgrades FactSet Research Systems (FDS) to Equalweight